Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,500
Employees4,500
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,500
Employees4,500

PEN Key Statistics

Market cap
12.35B
Market cap12.35B
Price-Earnings ratio
73.91
Price-Earnings ratio73.91
Dividend yield
Dividend yield
Average volume
582.86K
Average volume582.86K
High today
$320.00
High today$320.00
Low today
$307.00
Low today$307.00
Open price
$319.75
Open price$319.75
Volume
761.63K
Volume761.63K
52 Week high
$320.00
52 Week high$320.00
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

Penumbra(PEN) stock is priced at $315.35, giving the company a market capitalization of 12.35B. It carries a P/E multiple of 73.91.

On 2025-12-19, Penumbra(PEN) stock traded between a low of $307.00 and a high of $320.00. Shares are currently priced at $315.35, which is +2.7% above the low and -1.5% below the high.

The Penumbra(PEN)'s current trading volume is 761.63K, compared to an average daily volume of 582.86K.

During the past year, Penumbra(PEN) stock moved between $221.26 at its lowest and $320.00 at its peak.

During the past year, Penumbra(PEN) stock moved between $221.26 at its lowest and $320.00 at its peak.

PEN News

TipRanks 20h
Penumbra: Accelerating Growth, Margin Upside, and 2026+ Catalysts Support Overweight (Buy) Rating

In a report released today, Robbie Marcus from J.P. Morgan maintained a Buy rating on Penumbra, with a price target of $370.00. Claim 50% Off TipRanks Premium a...

TipRanks 2d
Penumbra: Top Pick for 2026 with Strong Growth Catalysts and Margin Improvements

Analyst Michael Matson of Needham maintained a Buy rating on Penumbra, boosting the price target to $388.00. Claim 50% Off TipRanks Premium and Invest with Conf...

Analyst ratings

86%

of 21 ratings
Buy
85.7%
Hold
9.5%
Sell
4.8%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.